ARTICLE | Company News
Myriad Genetics, Pharmacia deal
November 5, 2001 8:00 AM UTC
MYGN will use its sequencing technologies to analyze population samples to identify genetic polymorphisms in the general population. PHA and MYGN will explore commercialization of the resulting techno...